PLoS ONE (Jan 2019)

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.

  • Markus Riegersperger,
  • Max Plischke,
  • Anita Jallitsch-Halper,
  • Corinna Steinhauser,
  • Manuela Födinger,
  • Wolfgang C Winkelmayer,
  • Daniela Dunkler,
  • Gere Sunder-Plassmann

DOI
https://doi.org/10.1371/journal.pone.0218709
Journal volume & issue
Vol. 14, no. 7
p. e0218709

Abstract

Read online

TRIAL REGISTRATION:PEP Study: Ethics committee N° 393/2004, EudraCT 2004-004209-98. PEP-X Study: Ethics committee amendment application N° 154/01/2008. ClinicalTrials.gov NCT03751332.